The short version of GHRH receptor fits in a sentence. The long version — which is the one that helps — is below.
Reviewed 2026-08-01. Anything still debated is marked as such rather than presented as settled.
Two forms circulate under the CJC-1295 name, and they differ by a single appended group. The version without a drug affinity complex carries four substitutions along the peptide chain, including a D-alanine near the amino terminus and replacements at three other positions. These changes block the enzyme dipeptidyl peptidase IV and remove a methionine residue that is prone to oxidation. The modified fragment is frequently labeled MOD GRF 1-29. Naming conventions are inconsistent across informal sources, which is a common source of confusion.
The second form adds a maleimide-bearing linker to the lysine at the carboxyl end. This group reacts with cysteine-34 on circulating serum albumin, forming a covalent bond that keeps the peptide in the bloodstream for far longer. ConjuChem developed the molecule as a way to extend the action of a peptide without frequent administration. The albumin attachment is the defining structural feature of the drug affinity complex version. Whether continuous exposure produces effects distinct from shorter pulses remains an unresolved research question.
Studies in this area generally track growth hormone pulses, insulin-like growth factor 1 concentrations, and occasionally body composition endpoints. Most published human data come from early, small trials, and questions about long-term effects remain open. Whether repeated exposure alters pituitary responsiveness over time is not settled. Analytical work relies on immunoassays for the hormones and on mass spectrometry for the peptide itself, because the two measurements answer different questions.
Binding of the peptide to the growth hormone-releasing hormone receptor on pituitary somatotrophs triggers a G protein coupled cascade that raises cyclic AMP and opens calcium channels. The result is greater secretion of growth hormone into the bloodstream. Because the peptide acts at the same receptor as the natural hypothalamic hormone, its effect is amplified pulse size rather than an entirely separate release pathway. Receptor binding alone does not determine the response, since somatostatin tone and other inputs modulate the final output.
The albumin-binding version stays in circulation for days, because covalent attachment to serum albumin shields the peptide from rapid filtration and degradation. Reported half-lives for this form fall in the range of several days. The version without the linker is cleared in minutes, with estimates often near thirty minutes in animal work. These figures come from small studies and vary with assay method, species, and route, so they are best read as approximate rather than fixed constants.
| Property | Value | Notes |
|---|---|---|
| Target receptor | GHRH receptor (GHRHR) | Expressed on pituitary somatotrophs |
| Primary action | Stimulates growth hormone release | Amplifies pulse size |
| Half-life, albumin-binding form | Several days as reported | Slow release from albumin complex |
| Half-life, unmodified analog | About 30 minutes in animal estimates | Cleared by proteases and filtration |
| Common analytical approach | LC-MS/MS for peptide, immunoassay for hormones | Methods answer different questions |
Clearance profiles diverge sharply between the two versions. The albumin-binding molecule stays in plasma for several days, whereas the unmodified analog is largely gone within about half an hour in reported work. Cleavage by dipeptidyl peptidase IV is a major contributor to the short life of the unmodified sequence. These gaps mean the two versions cannot be substituted for each other in study design or in reading results side by side.
Reports on this compound commonly follow serum growth hormone and insulin-like growth factor 1 across defined time windows. Protocols differ in sampling frequency, assay platform, and participant characteristics, which makes direct comparison between publications difficult. Some work focuses on pulsatile release patterns instead of average concentrations. Whether repeated exposure alters endogenous hormone rhythms over long periods remains an open question, and the formal literature is thinner than the volume of informal commentary implies.
Once in circulation, the peptide binds the growth hormone-releasing hormone receptor displayed on pituitary somatotroph cells. Receptor activation couples to Gs proteins, elevates intracellular cyclic AMP, and drives protein kinase A signaling inside the cell. That cascade increases discharge of growth hormone into the bloodstream. The analog therefore operates through a receptor pathway that already exists for the body's own releasing hormone, rather than through an engineered artificial target.
CJC-1295 belongs to a class of synthetic peptides modeled on growth hormone releasing hormone, a forty-four amino acid signal produced by the hypothalamus. The compound is built from the first twenty-nine residues of the natural sequence, with four substitutions introduced at positions 2, 8, 15 and 27. These changes were designed to slow enzymatic breakdown while preserving receptor activation. The result is a peptide that is shorter than native GHRH and considerably more resistant to ordinary clearance pathways in circulation.
Two related forms appear under the CJC-1295 name. The simpler analogue, commonly written as modified GRF(1-29), carries the four substitutions but no additional conjugation. The second form attaches a maleimidopropionic acid linker to a lysine residue, a modification frequently called the drug affinity complex. That linker reacts with the free thiol on serum albumin to form a covalent bond. Because albumin has a long residence time in blood, the conjugated peptide stays in circulation far longer than the unconjugated analogue.
Enzymatic protection is a separate mechanism from plasma protein binding. The four substitutions in the backbone reduce recognition by dipeptidyl peptidase IV, which normally cleaves the natural hormone within minutes. Without the reactive group, this resistance still yields only a short window of activity, generally reported in the range of tens of minutes. With it, reported half-lives in early human work extended to several days. The size of that gap is the main practical distinction between the two materials.
Both forms act at the pituitary receptor for growth hormone-releasing hormone and increase growth hormone output, which in turn raises insulin-like growth factor 1. A long-acting analog produces sustained rather than pulsatile stimulation, and the physiological consequences of that pattern are not fully settled. Published human data on the extended form remain limited, and much of what circulates in discussion traces to early company reports rather than independent replication. How sustained exposure affects normal feedback remains an open question.
The distinguishing feature of the DAC form is a maleimide-containing group that reacts with the free thiol of cysteine-34 on human serum albumin. This reaction forms a covalent bond without enzymatic assistance, and it takes place after the peptide enters the bloodstream. Because albumin is abundant and long-lived, the attached peptide is carried through circulation far longer than an unmodified fragment would survive. The chemistry is a deliberate pharmacokinetic strategy rather than a change to receptor activity.
Pre-mature (early) cultivars are harvested before the end of July, serotinous (late) cultivars from September on, and mid-serotinous or mid-matutinal cultivars are in between these harvest times. Using pre-mature cultivars, rhizomes can be harvested earlier and sold for a higher price. Adlittoral (shallow), deep, and intermediate cultivars are distinguished according to the depth in which the rhizomes grow underground. Adlittoral cultivars range from 10 to 20 cm (3.9 to 7.9 in) depth and are often premature. They develop faster due to higher temperatures in surface soil layers. When harvested in July, adlittorals have higher yields than deeper-growing cultivars, but not necessarily when harvested in September. Rhizomes of adlittoral cultivars are crisp and good for frying purposes. Deep cultivars grow more than 40 cm (16 in) deep. They are often serotinous and can harvest high yields. Their rhizomes are starch-rich. The main popular Nelumbo nucifera cultivars in China are Elian 1, Elian 4, Elian 5, 9217, Xin 1, and 00–01. The average yield of these cultivars is 7.5–15 t/ha (3.3–6.7 tons/acre) of harvest in July and 30–45 t/ha (13–20 tons/acre) of harvest in September. In Australia, the cultivar grown for the fresh rhizome market in Guangdong and Japan, the common rhizome cultivars are Tenno and Bitchu.
Buba Baldeh- former Minister for Youth Sports and Culture Under the PPP Regime. He is the son of the Late Micheal Baldeh who was a member of Parliament in the first Republic. Dawda Bah Samuel Kargbo- Football player Musa Barrow- Football player Musa Juwara Hamza Barry Muhammed Badamosi Seedy Bah
==== Common causes of chronic wounds ==== Diabetes mellitus – Wound healing impairment in the setting of diabetes is multifactorial. Hyperglycemia, neuropathy, microvascular complications, impaired immune and inflammatory responses, and psychological factors have all been implicated in the formation and propagation of diabetic wounds. Feet are the most common location of diabetic wounds, although any type of wound can be negatively impacted by diabetes. It has been estimated that up to 25% of patients with diabetes mellitus will be affected by non-healing wounds in their lifetime. Venous/Arterial insufficiency – Impaired blood outflow (venous) or inflow (arterial) can both impair wound healing, thereby causing chronic wounds. Much like diabetes, venous/arterial insufficiency most commonly result in chronic wounds of the lower extremities. In chronic venous insufficiency, blood pooling impedes oxygen exchange and creates a chronic pro-inflammatory environment which both promote formation of venous ulcers. Peripheral artery disease, on the other hand, causes wounds due to poor blood inflow and typically affects the most distal extremities (fingers, toes). Immunologic disease – The immune system plays a critical role in the inflammatory process; therefore, any disease of the immune system has the potential to impair the inflammatory phase of wound healing, thereby leading to a chronic wound. Patients suffering from diseases such as rheumatoid arthritis and lupus have been found to have larger wounds and prolonged time to heal when compared to the general population.
== History == Thiobuscaline was first described in the scientific literature by Alexander Shulgin and Peyton Jacob III in 1984. Subsequently, it was described in greater detail by Shulgin in his book PiHKAL (Phenethylamines I Have Known and Loved) in 1991.
In osteology, the osteon or haversian system (; named for Clopton Havers) is the fundamental functional unit of much compact bone. Osteons are roughly cylindrical structures that are typically between 0.25 mm and 0.35 mm in diameter. Their length is often hard to define, but estimates vary from several millimeters to around 1 centimeter. They are present in many bones of most mammals and some bird, reptile, and amphibian species.
Sources: en.wikipedia.org
=== Infection transmission === Semen can transmit many sexually transmitted infections and pathogens, including viruses like HIV and Ebola. Swallowing semen carries no additional risk other than those inherent in fellatio. This includes transmission risk for sexually transmitted infections such as human papillomavirus or herpes, especially for people with bleeding gums, gingivitis or open sores. Viruses in semen survive for a long time once outside the body.
Earlier studies found mean elimination rates of 15 mg/dL per hour for men and 18 mg/dL per hour for women, but Jones found 0.148 g/L/h and 0.156 g/L/h respectively. Although the difference between sexes is statistically significant, it is small compared to the overall uncertainty, so Jones recommends using the value 0.15 for the mean for all subjects. This mean rate is very roughly 8 grams of pure ethanol per hour (one British unit). Explanations for the gender difference are quite varied and include liver size, secondary effects of the volume of distribution, and sex-specific hormones. A 2023 study using a more complex two-compartment model with M-M elimination kinetics, with data from 60 men and 12 women, found statistically small effects of gender on maximal elimination rate and excluded them from the final model. At concentrations below 0.15-0.20 g/L, alcohol is eliminated more slowly and the elimination rate more closely follows first-order kinetics. The overall behavior of the elimination rate is described well by Michaelis–Menten kinetics. This change in behavior was not noticed by Widmark because he could not analyze low BAC levels. The rate of elimination of ethanol is also increased at very high concentrations, such as in overdose, again more closely following first-order kinetics, with an elimination half-life of about 4 or 4.5 hours (a clearance rate of approximately 6 L/hour/70 kg). This is thought to be due to increased activity of CYP2E1. Eating food in proximity to drinking increases elimination rate significantly, mainly due to increased metabolism.
== Structural function in proteins == Since the asparagine side-chain can form hydrogen bond interactions with the peptide backbone, asparagine residues are often found near the beginning of alpha-helices as asx turns and asx motifs, and in similar turn motifs, or as amide rings, in beta sheets. Its role can be thought as "capping" the hydrogen bond interactions that would otherwise be satisfied by the polypeptide backbone. Asparagine also provides key sites for N-linked glycosylation, modification of the protein chain with the addition of carbohydrate chains. Typically, a carbohydrate tree can solely be added to an asparagine residue if the latter is flanked on the C side by X-serine or X-threonine, where X is any amino acid with the exception of proline. Asparagine can be hydroxylated in the HIF1 hypoxia-inducible transcription factor. This modification inhibits HIF1-mediated gene activation.
The park was closed for renovations on July 11, 1988. The four-year project to rebuild Bryant Park entailed new entrances, repairs to paths and lighting, and a redesign of the park's garden by Lynden Miller. Biederman worked with William H. Whyte, a sociologist whose influence led them to implement two decisions. One was the placement of 2,000 movable chairs in the park. The other was to lower the park itself, because Bryant Park had been elevated from the street and isolated by tall hedges prior to the 1988 redesign. The 1988 renovation lowered the park to nearly street level and tore out the hedges, though much of the park was still slightly elevated. The park's restrooms, which had been closed for 35 years, were renovated as well. The BPRC also found that several of the sculptures would need to be repaired, and called on William Cullen Bryant's descendants and other entities to provide funding for the restoration of these sculptures. Landscape architect Laurie Olin of Hanna/Olin recalls that the design process focused on "the different abilities of people [who] use these spaces...as well as making spaces that people are comfortable being with each other in." The restoration cost $8.9 million, which included $5.7 million of city funding and $3.2 million of private funding. The renovation took place at the same time as the NYPL's expansion of the main branch's stacks underneath Bryant Park.
Sources: en.wikipedia.org
The geography cone snail is highly venomous; live specimens should be handled with extreme caution. C. geographus has the most toxic sting known among Conus species and there are reports for about 36 human fatalities over the past 300 years. The venom has a median lethal dose in the range of 0.012–0.030 mg/kg. The venom of the geography cone snail is a complex mix of hundreds of different toxins that is delivered through a toxoglossan radula, a harpoon-like tooth propelled from an extendable proboscis. There is no antivenom for a cone snail sting, and treatment consists of keeping victims alive until symptoms wear off. The geography cone is also known colloquially as the "cigarette snail", a gallows humor exaggeration implying that, when stung by this creature, the victim will have only enough time to smoke a cigarette before dying. In reality, even the most venomous cone snails take about one to five hours to kill a healthy human, though medical care must still be prompt as, without it, death is almost certain. Among the compounds found in cone snail venom are proteins which, when isolated, have great potential as pain-killing drugs. Research shows that certain component proteins of the venom target specific human pain receptors and can be up to 10,000 times more effective than morphine, without morphine's addictive properties and side effects. Conotoxin-G is a toxin derived from the venom of C. geographus. Only 15–20 of the venom's 100–200 toxic peptides are used for feeding.
== Fort Montgomery chain (1776–1777) == In 1776 a chain and boom were stretched across the river from Fort Montgomery on the west bank, at the lower entrance to the Highlands just north of the modern-day Bear Mountain Bridge, to Anthony's Nose on the east bank. Captain Thomas Machin headed the chain effort. In November 1776, a faulty link broke under stress induced by the river current, highlighting some of the difficulties of trying to chain the Hudson. It was repaired and reset. After the British captured forts Montgomery and Clinton, a second fortress built opposite it at the mouth of Popolopen's Kill (today's Popolopen Creek) on its south bank, on October 6, 1777, they dismantled the chain. Free to do so, they raided upriver as far as Kingston, then the capitol of New York State, putting the torch to it and burning all but several of its hundreds of buildings to the ground. Governor George Clinton, a member of the committee assigned by the New York Convention to devise a means of defending the Hudson, was heartened as the British had never attempted to run ships through the chain. He concluded that the basic idea of obstructing the river seemed sound. After Captain Machin recovered from wounds from battle with the British, he began work on the stronger Great Chain at West Point, which was constructed and installed in 1778.
The deep veins of the lower limb include the common femoral vein, femoral vein, and the deep femoral vein; the popliteal vein, the tibial, and fibular veins. In the common femoral vein one valve is located above the saphenofemoral junction called the suprasaphenic valve. There are sometimes two valves in the same tract. In the femoral vein there are often three valves, the most constantly found valve is just below the joining of the deep femoral vein. The deep femoral vein and its perforators have valves. In the popliteal veins there are between one and three valves; in each posterior tibial vein there are between 8 and 19 valves, and in the anterior tibial veins there are between 8 and 11 valves. In the superficial veins there are between one and seven valves along the thigh portion of the great saphenous vein (GSV); two to six below the knee and one to four in the marginal veins of the foot. There is a valve at the termination of the GSV known as the terminal valve to prevent reflux from the femoral vein. A preterminal valve is located just below the openings of the tributaries to prevent reflux form these into the GSV. Incompetence of the GSV is a common cause of varicose veins. The valves also divide the column of blood into segments which helps move the blood unidirectionally to the heart. Their action is supported by the action of skeletal muscle pumps that contract and compress the veins. A skeletal muscle is confined in its fascia and contraction of the muscle which makes it wider results In compression on the vein that pushes the blood forward.
Sources: en.wikipedia.org
Reported values cluster in the range of several days, reflecting slow release from the albumin complex. Estimates differ across species and assay platforms. The figure describes circulation time in study settings rather than a fixed property.
Typical endpoints include growth hormone pulse frequency and amplitude, together with insulin-like growth factor 1 concentration. Some protocols add body composition or metabolic markers. Interpretation depends on baseline hormonal status, which varies widely between individuals.
Most human data come from small, early-stage studies, and independent replication is limited. Short-term effects on growth hormone release are documented; longer-term outcomes are not well characterized. Open questions include changes in pituitary responsiveness after repeated exposure.
It acts on the growth hormone-releasing hormone receptor found on pituitary somatotroph cells. Activation of that receptor triggers growth hormone release through a cyclic AMP dependent pathway.